Behepan vitamin B12

Behepan is a well-established pharmaceutical product used primarily for treating vitamin B12 deficiency. Originally developed in Sweden as part of the country's robust pharmaceutical innovation sector, the brand has historically been associated with Swedish healthcare providers and major pharmaceutical companies like Kabi Vitrum.

Today, Behepan is part of the portfolio of Viatris Inc., a global healthcare company formed through the combination of Mylan and Pfizer's Upjohn division. While the brand has Swedish roots, manufacturing occurs across a global network of production facilities to ensure supply to Northern European markets. This global ownership structure reflects the consolidated nature of the modern pharmaceutical industry, where classic local brands are managed by multinational corporations based in the United States.